ASX News
Imugene kicks off Australian trial for blood cancer treatment
Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test CAR T cell therapy azer-cel
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ENB | Ann: Entitlement Offer Timetable update | 26/03/19 | 0 | 75 | |||
|
|||||||
| ENB | Ann: Entitlement offer notice to shareholders | 26/03/19 | 0 | 69 | |||
|
|||||||
| ENB | Ann: Entitlement offer notice to ineligible shareholders | 26/03/19 | 0 | 55 | |||
|
|||||||
| ENB | Ann: Amended Appendix 3B Non Renounceable Entitlement Offer | 25/03/19 | 0 | 62 | |||
|
|||||||
| ENB | Ann: Confirms Termination of Argentina Lithium Transaction | 25/03/19 | 9 | 914 | |||
|
|||||||
| ENB | Ann: Notice to Option Holders - non-renounceable pro rata offer | 25/03/19 | 0 | 76 | |||
|
|||||||
| ENB | Ann: Appendix 3B Non Renounceable Entitlement Offer | 22/03/19 | 0 | 85 | |||
|
|||||||
| ENB | Ann: Prospectus for Non Renounceable Entitlement Offer | 22/03/19 | 0 | 106 | |||
|
|||||||
See All Discussions
